JorgeAGarciaMDFACP

Genitourinary Oncology, Hematologic Oncology

The Kerscher Family Chair for Clinical Prostate Cancer Research Assistant Professor, Medicine, Case Western Reserve University School of Medicine Staff Physician, Solid Tumor Oncology and Urology. Director, Advanced Prostate Cancer Research Program

Join to view full profile

Dr. Garcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Garcia's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 800-223-2273

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2001 - 2004
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolPost-Doctoral Fellowship, 1995 - 1998
Escuela Colombiana de MedicinaClass of 1994

Certifications & Licensure

CA State Medical License 2001 - Present
OH State Medical License 2004 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Enzalutamide in Patients With High-risk Prostate Cancer Start of enrollment: 2013 Nov 11
Completed
Phase 2
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer Start of enrollment: 2016 Oct 17
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder can...
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, Adrian S Fairey, Colin P Dinney
World Journal of Urology. 2022-11-01
6 citations
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805.
Alicia K Morgans, Yu-Hui Chen, David F Jarrard, Michael Carducci, Glenn Liu
The Prostate. 2022-09-01
6 citations
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, Alejandro Berlin, Alison Tree
International Journal of Radiation Oncology, Biology, Physics. 2022-06-01

Journal Articles

The Association Between Facility Case Volume and Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
Timothy Gilligan, Jorge A Garcia, Brian I Rini, Urologic Oncology

Press Mentions

AUA 2018: Tumor Board: Prostate CancerMay 18th, 2018
Experts Explain Impact of LATITUDE Abiraterone Data in Prostate CancerAugust 2nd, 2017
Onclive® Announces State of the Science Summit™: Genitourinary CancersMay 4th, 2017
Join now to see all